Special Edition
Life Science Nation Newsletter | October 19, 2017 | Issue 236


  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (Oct. 12  - Oct. 18)
Looks Worldwide for Cutting Edge Clinical Stage Therapeutics
Closes New Early Stage Therapeutics Fund
Looks for Innovative Technologies in CNS, Kidney Disorders and Oncology
Turns Focus to Life Sciences, Seeks Products for China Market
Invests in Early Stage Therapeutics
Invests in Small Molecules and Biologics in Cardiology, Immunology, CNS, And More
Looks Across the USA for Early Stage Life Science Startups
Invests in Preclinical Drugs and Prototype-Stage Devices
Invests in Preventative Healthcare and Value Based Care
Invests in Life Science Companies with China Representation
In This Issue
News
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Services
Click to see investors that are a fit for your product and stage of development

Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you

Click here if you want to receive free, targeted early stage dealflow for your life science investment firm

Free Copy of LSN's Book

LSN Videos
By Natasha Eldridge, Director of RESI Conference Series, LSN

Next Monday, October 23rd, the RESI Partnering Platform will open for the first RESI NYC, and the hundreds of entrepreneurs and investors who are signed up for RESI will have the opportunity to start booking one-on-one meetings.

If you've signed up for RESI's Premier Partnering Plus, you will be able to access deep profiles of investors and strategic players that can be used to ensure you are targeting the most relevant investors in attendance. As well as providing an extra tool to vet the firms you're reaching out to, Premier Partnering Plus includes contact info to help reach investors and secure meetings. If you're already registered and would like to talk about upgrading your registration, please contact us at resi@lifesciencenation.com.

Beyond Partnering, RESI will offer 24 panels and workshops featuring more than 100 speakers focused on early-stage investment, and provide an engaging venue for ad-hoc networking on NYC's up-and-coming biotech scene.

We hope you're all ready to start filling out your dance card for RESI NYC. The price to attend RESI will increase by $200 after Friday, October 20th - if you'd like to take part in RESI Partnering, don't delay in signing up.

By Lucy Parkinson, Director of Research, LSN

The first RESI NYC event has attracted a great diversity of constituents - from local startups to global investors, from New York-based foundations to major pharma and medtech firms from the Asia region. RESI always aims to draw investors beyond the well-trodden traditional funding tracks of venture capital funds, local angels and pharma; LSN is delighted to have those groups on board too, but at RESI you can also meet family offices, private equity and hedge funds, and the varied investment and strategic groups that participate in our Asia - North America track. Who would you like to meet at RESI NYC? Take a look below at some of the possibilities.


Confirmed Investors and Strategic Partners
As of October 19th, 2017

QuickFire Challenge
I n honor of the Grand Opening of JLABS @ NYC, Johnson & Johnson Innovation has launched a QuickFire Challenge to award up to four new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ NYC community for one year.

This competition will award the person or team(s) who submits the best idea, technology, or solution in the following areas:
  • Consumer healthcare
  • Health technologies
  • Medical devices
  • Therapeutics